Yu Dong

1.0k total citations · 1 hit paper
31 papers, 675 citations indexed

About

Yu Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Dong has authored 31 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yu Dong's work include Cancer-related molecular mechanisms research (4 papers), Toxic Organic Pollutants Impact (3 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Yu Dong is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Toxic Organic Pollutants Impact (3 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Yu Dong collaborates with scholars based in China, United States and Australia. Yu Dong's co-authors include Qiong Xu, Meirui Zhong, Xiaoyin Niu, Youqiong Ye, Duan Ni, Rujuan Bao, Gaoyang Wang, Yanhua Du, Huabing Li and Huifang Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Dong

31 papers receiving 668 citations

Hit Papers

Digital finance and rural revitalization: Empirical test ... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Dong China 14 333 228 117 92 51 31 675
G. Raghuram India 20 340 1.0× 153 0.7× 71 0.6× 76 0.8× 60 1.2× 59 848
Meilan Chen China 19 317 1.0× 46 0.2× 116 1.0× 76 0.8× 109 2.1× 103 1.2k
Min Song China 21 645 1.9× 240 1.1× 54 0.5× 213 2.3× 14 0.3× 61 1.2k
Wenwen Wang China 20 247 0.7× 86 0.4× 121 1.0× 45 0.5× 260 5.1× 53 974
Xinyue Deng China 16 478 1.4× 282 1.2× 45 0.4× 110 1.2× 9 0.2× 43 1.1k
Hongjun Lv China 17 437 1.3× 71 0.3× 69 0.6× 84 0.9× 31 0.6× 34 1.1k
Shushu Li China 12 208 0.6× 67 0.3× 85 0.7× 20 0.2× 78 1.5× 37 642
Yajing Zhang China 20 756 2.3× 408 1.8× 58 0.5× 142 1.5× 10 0.2× 56 1.1k
Xinru Zhou China 24 601 1.8× 253 1.1× 60 0.5× 122 1.3× 58 1.1× 58 1.3k
Xiaobin Ma China 21 536 1.6× 254 1.1× 37 0.3× 201 2.2× 26 0.5× 63 1.2k

Countries citing papers authored by Yu Dong

Since Specialization
Citations

This map shows the geographic impact of Yu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Dong more than expected).

Fields of papers citing papers by Yu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Dong. The network helps show where Yu Dong may publish in the future.

Co-authorship network of co-authors of Yu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Dong. A scholar is included among the top collaborators of Yu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Dong. Yu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yu, Wei Wei, Jian Jiao, et al.. (2024). A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib. Journal of Cancer Research and Clinical Oncology. 150(2). 95–95. 2 indexed citations
2.
Xu, Qiong, Meirui Zhong, & Yu Dong. (2024). Digital finance and rural revitalization: Empirical test and mechanism discussion. Technological Forecasting and Social Change. 201. 123248–123248. 49 indexed citations breakdown →
3.
Dong, Yu, Rui‐Hua Xu, Xiaowei Chen, et al.. (2023). Characterization of gut microbiota in adults with coronary atherosclerosis. PeerJ. 11. e15245–e15245. 13 indexed citations
4.
Dong, Yu, et al.. (2022). Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli. Microbiology Spectrum. 10(5). e0109322–e0109322. 1 indexed citations
6.
Zhao, Lisha, et al.. (2022). Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice. Oxidative Medicine and Cellular Longevity. 2022(1). 4301033–4301033. 11 indexed citations
7.
Sun, Jiatong, Xiaocui Xu, You Wu, et al.. (2022). Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming. Stem Cell Reports. 17(8). 1799–1809. 12 indexed citations
8.
Wang, Yanan, Xiaowei Chen, Fei Jiang, et al.. (2022). A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity. Frontiers in Genetics. 13. 939439–939439. 10 indexed citations
9.
Chen, Huifang, Jiameng Yao, Rujuan Bao, et al.. (2021). Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer. Molecular Cancer. 20(1). 29–29. 164 indexed citations
10.
Wang, Xin, Meiai Lin, Changyu Li, et al.. (2020). Gynura divaricata exerts hypoglycemic effects by regulating the PI3K/AKT signaling pathway and fatty acid metabolism signaling pathway. Nutrition and Diabetes. 10(1). 31–31. 19 indexed citations
11.
Dong, Yu, Yang Xiao, Qihui Shi, & Chunjie Jiang. (2020). Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma. Frontiers in Genetics. 10. 1284–1284. 15 indexed citations
12.
Zhang, Zhenfeng, Tianyu Zhang, Hongwei Geng, et al.. (2019). Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Chen, Jian‐Zhang, et al.. (2019). Applications of Constacyclic Codes to Some New Entanglement-Assisted Quantum MDS Codes. IEEE Access. 7. 136641–136657. 3 indexed citations
14.
Liu, Chunliang, et al.. (2019). Survival-based bioinformatics analysis to identify hub genes and key pathways in non-small cell lung cancer. Translational Cancer Research. 8(4). 1188–1198. 1 indexed citations
15.
Tian, Chen, Yu Dong, Luping Yang, et al.. (2019). Thyroid function and decabromodiphenyl ethane (DBDPE) exposure in Chinese adults from a DBDPE manufacturing area. Environment International. 133(Pt A). 105179–105179. 51 indexed citations
16.
Li, Ziming, Zhuo Wang, Yin Tang, et al.. (2019). Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics. Nature Communications. 10(1). 3856–3856. 39 indexed citations
17.
Zhang, Guanghui, Kun Du, Wenjuan Wang, et al.. (2019). Retinol-binding protein 4, fetal overgrowth and fetal growth factors. Pediatric Research. 87(5). 946–951. 5 indexed citations
18.
Wu, Li, You Wu, Bing Peng, et al.. (2017). Oocyte-Specific Homeobox 1, Obox1, Facilitates Reprogramming by Promoting Mesenchymal-to-Epithelial Transition and Mitigating Cell Hyperproliferation. Stem Cell Reports. 9(5). 1692–1705. 13 indexed citations
19.
Guo, Yinsheng, Jiajia Ji, Wei Wang, et al.. (2015). Role of Endoplasmic reticulum apoptotic pathway in testicular Sertoli cells injury induced by Carbon disulfide. Chemosphere. 132. 70–78. 6 indexed citations
20.
Guo, Yinsheng, Wei Wang, Yu Dong, et al.. (2014). Carbon disulfide induces rat testicular injury via mitochondrial apoptotic pathway. Chemosphere. 108. 367–375. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026